Key facts
- This page summarizes Timothy Wright's Form 4 filing for AGENUS INC (AGEN).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 08 Feb 2022, 17:16.
Timothy Wright - 04 Feb 2022 Form 4 Insider Report for AGENUS INC (AGEN)
- Reporting relationship
- Director
- Issuer ticker
- AGEN
- Reported as of
- 04 Feb 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 08 Feb 2022, 17:16:01 UTC
- Prior SEC filing
- 05 Jan 2022
- Next SEC filing
- 05 Apr 2022
- Source filing
- View source filing
- Reporting owner signature
- By: /s/ Christine Klaskin as Attorney-in-Fact for Timothy Wright
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Timothy Wright filed Form 4 for AGENUS INC (AGEN) on 08 Feb 2022.
Change
- Previous filing in this sequence was filed on 05 Jan 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AGEN
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +150,000
- Change %
- Price
- $0.000000
- Shares after
- 150,000
- Date
- 04 Feb 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 150,000
- Exercise price
- $2.39
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Option awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan, as amended, and will vest on February 4, 2023.